Literature DB >> 24955738

Telemedicine approaches to evaluating acute-phase retinopathy of prematurity: study design.

.   

Abstract

PURPOSE: Detecting sight-threatening retinopathy of prematurity (ROP) relies on a diagnostic examination (DE) performed by an experienced ophthalmologist. An alternative may be a telemedicine system where retinal images of at-risk infants are graded by readers to determine features of ROP indicating the need for a DE.
METHODS: The multicenter Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP) Study is a cohort study of 2000 infants with birth weights <1251 g. At each visit, ophthalmologists perform DEs and non-physician imagers obtain iris and five retinal images with the disc positioned in the center, right, left, up and down. Images are uploaded to a secure server for grading by non-physician readers for the detection of plus disease, stage 3 ROP and/or zone I disease, any of which indicates "referral-warranted ROP" (RW-ROP). Images from all infants with RW-ROP and a random sample of infants without RW-ROP (based on DEs) are selected for grading. Gradings are compared to DEs to determine the validity and evaluate reliability, feasibility, safety, and cost-effectiveness of the telemedicine system.
RESULTS: e-ROP is conducted in 12 Clinical Centers in the US and Canada with Study Headquarters, the Data Coordinating Center and the Image Reading Center in Philadelphia and the ROP Data Center in Oklahoma City. A total of 27 study center coordinators, 34 ophthalmologists, 26 imagers, and 4 readers have been certified. All study data are submitted using a secure web-based system.
CONCLUSION: The design and findings of this study will be useful to conduct other ROP studies or evaluate telemedicine for other diseases.

Entities:  

Keywords:  Childhood blindness; prematurity; retinopathy of prematurity; telemedicine

Mesh:

Year:  2014        PMID: 24955738      PMCID: PMC4861056          DOI: 10.3109/09286586.2014.926940

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  32 in total

1.  Telephotoscreening to detect retinopathy of prematurity: preliminary study of the optimum time to employ digital fundus camera imaging to detect ROP.

Authors:  Kimberly G Yen; Ditte Hess; Barbara Burke; Rose Anne Johnson; William J Feuer; John T Flynn
Journal:  J AAPOS       Date:  2002-04       Impact factor: 1.220

2.  Computer-automated quantification of plus disease in retinopathy of prematurity.

Authors:  David K Wallace; Julien Jomier; Steven R Aylward; Maurice B Landers
Journal:  J AAPOS       Date:  2003-04       Impact factor: 1.220

3.  Screening for retinopathy of prematurity using wide-field digital retinal imaging: sensitivity and specificity.

Authors:  Alistair R Fielder; Kenneth D Cocker; Antonio Capone; Michael T Trese
Journal:  Arch Ophthalmol       Date:  2002-09

4.  Cost-effectiveness of digital photographic screening for retinopathy of prematurity in the United Kingdom.

Authors:  Marianela C Castillo-Riquelme; Joanne Lord; Merrick J Moseley; Alistair R Fielder; Linda Haines
Journal:  Int J Technol Assess Health Care       Date:  2004       Impact factor: 2.188

5.  Detection of clinically significant retinopathy of prematurity using wide-angle digital retinal photography: a report by the American Academy of Ophthalmology.

Authors:  Michael F Chiang; Michele Melia; Angela N Buffenn; Scott R Lambert; Franco M Recchia; Jennifer L Simpson; Michael B Yang
Journal:  Ophthalmology       Date:  2012-04-27       Impact factor: 12.079

6.  Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera.

Authors:  S D Schwartz; S A Harrison; P J Ferrone; M T Trese
Journal:  Ophthalmology       Date:  2000-01       Impact factor: 12.079

7.  Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1990-02

8.  Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies.

Authors:  James D Reynolds; Velma Dobson; Graham E Quinn; Alistair R Fielder; Earl A Palmer; Richard A Saunders; Robert J Hardy; Dale L Phelps; John D Baker; Michael T Trese; David Schaffer; Betty Tung
Journal:  Arch Ophthalmol       Date:  2002-11

9.  Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study.

Authors:  Anna L Ells; Jonathan M Holmes; William F Astle; Geoff Williams; David A Leske; Michael Fielden; Brad Uphill; Penny Jennett; Marilynne Hebert
Journal:  Ophthalmology       Date:  2003-11       Impact factor: 12.079

10.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  2003-12
View more
  23 in total

1.  Training retinal imagers for retinopathy of prematurity (ROP) screening.

Authors:  Karen A Karp; Agnieshka Baumritter; Denise J Pearson; Maxwell Pistilli; Darla Nyquist; Michele Huynh; Kelli Satnes; Rachel Keith; Gui-Shuang Ying; Graham E Quinn
Journal:  J AAPOS       Date:  2016-05-06       Impact factor: 1.220

2.  Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study.

Authors:  Gui-Shuang Ying; Deborah VanderVeen; Ebenezer Daniel; Graham E Quinn; Agnieshka Baumritter
Journal:  Ophthalmology       Date:  2016-08-02       Impact factor: 12.079

3.  Safety of Retinopathy of Prematurity Examination and Imaging in Premature Infants.

Authors:  Kelly C Wade; Maxwell Pistilli; Agnieshka Baumritter; Karen Karp; Alice Gong; Alex R Kemper; Gui-Shuang Ying; Graham Quinn
Journal:  J Pediatr       Date:  2015-08-20       Impact factor: 4.406

4.  Single grading vs double grading with adjudication in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study.

Authors:  Ebenezer Daniel; Wei Pan; Graham E Quinn; Eli Smith; Agnieshka Baumritter; Gui-Shuang Ying
Journal:  J AAPOS       Date:  2017-12-20       Impact factor: 1.220

5.  Intereye Agreement of Retinopathy of Prematurity from Image Evaluation in the Telemedicine Approaches to Evaluating of Acute-Phase ROP (e-ROP) Study.

Authors:  Gui-Shuang Ying; Wei Pan; Graham E Quinn; Ebenezer Daniel; Michael X Repka; Agnieshka Baumritter
Journal:  Ophthalmol Retina       Date:  2017 Jul-Aug

6.  Intraocular Hemorrhages and Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.

Authors:  Ebenezer Daniel; Gui-Shuang Ying; R Michael Siatkowski; Wei Pan; Eli Smith; Graham E Quinn
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

7.  Impact of number and quality of retinal images in a telemedicine screening program for ROP: results from the e-ROP study.

Authors:  David Morrison; Erick D Bothun; Gui-Shuang Ying; Ebenezer Daniel; Agnieshka Baumritter; Graham Quinn
Journal:  J AAPOS       Date:  2016-10-01       Impact factor: 1.220

8.  Plus Disease in Retinopathy of Prematurity: Improving Diagnosis by Ranking Disease Severity and Using Quantitative Image Analysis.

Authors:  Jayashree Kalpathy-Cramer; J Peter Campbell; Deniz Erdogmus; Peng Tian; Dharanish Kedarisetti; Chace Moleta; James D Reynolds; Kelly Hutcheson; Michael J Shapiro; Michael X Repka; Philip Ferrone; Kimberly Drenser; Jason Horowitz; Kemal Sonmez; Ryan Swan; Susan Ostmo; Karyn E Jonas; R V Paul Chan; Michael F Chiang
Journal:  Ophthalmology       Date:  2016-08-24       Impact factor: 12.079

9.  Factors in Premature Infants Associated With Low Risk of Developing Retinopathy of Prematurity.

Authors:  Kelly C Wade; Gui-Shuang Ying; Agnieshka Baumritter; Alice Gong; Alex R Kemper; Graham E Quinn
Journal:  JAMA Ophthalmol       Date:  2019-02-01       Impact factor: 7.389

10.  Timely implementation of a retinopathy of prematurity telemedicine system.

Authors:  Graham E Quinn; Gui-Shuang Ying; Michael X Repka; R Michael Siatkowski; Robert Hoffman; Monte D Mills; David Morrison; Ebenezer Daniel; Agnieshka Baumritter; P Lloyd Hildebrand; Eleanor B Schron; Anna L Ells; Kelly Wade; Alex R Kemper
Journal:  J AAPOS       Date:  2016-09-17       Impact factor: 1.220

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.